Have your own idea? Try our Stock Screener
Polish (WIG) Life Sciences Industry Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies5
- 7D-7.4%
- 3M-15.1%
- 1Y-17.7%
- YTD-14.8%
The Life Sciences is pretty flat in the last 7 days, but Ryvu Therapeutics has stood out, gaining 7.0%. As for the longer term, the industry has declined 16% in the last year. As for the next few years, earnings are expected to grow by 8.1% per annum.
Industry Valuation and Performance
Has the Polish Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | zł2.2b | zł421.9m | -zł72,811,689.00 | 20.3x | -30x | 5.2x |
| Sat, 19 Oct 2024 | zł2.4b | zł413.2m | -zł64,500,689.00 | 23.2x | -36.8x | 5.7x |
| Mon, 16 Sep 2024 | zł2.5b | zł421.4m | -zł39,488,869.00 | 18x | -62.7x | 5.9x |
| Wed, 14 Aug 2024 | zł2.4b | zł413.4m | -zł36,839,029.00 | 17.3x | -65.6x | 5.9x |
| Fri, 12 Jul 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 19.4x | -78.6x | 6.1x |
| Sun, 09 Jun 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 18.6x | -78.2x | 6.1x |
| Tue, 07 May 2024 | zł2.5b | zł421.0m | -zł26,364,957.00 | 18.4x | -96.6x | 6.1x |
| Thu, 04 Apr 2024 | zł2.6b | zł421.0m | -zł26,364,957.00 | 17.5x | -97.2x | 6.1x |
| Sat, 02 Mar 2024 | zł2.5b | zł495.9m | -zł52,637,957.00 | 44.4x | -48x | 5.1x |
| Mon, 29 Jan 2024 | zł2.4b | zł495.2m | -zł50,454,191.00 | 43.8x | -47.9x | 4.9x |
| Wed, 27 Dec 2023 | zł2.6b | zł495.2m | -zł50,454,191.00 | 45.6x | -51.4x | 5.2x |
| Fri, 24 Nov 2023 | zł2.6b | zł484.4m | -zł46,593,727.00 | 51.2x | -54.8x | 5.3x |
| Sun, 22 Oct 2023 | zł2.9b | zł512.0m | -zł37,354,934.00 | 33.8x | -78.8x | 5.7x |
| Tue, 19 Sep 2023 | zł2.8b | zł515.2m | -zł42,853,934.00 | 41.2x | -65.6x | 5.5x |
| Thu, 17 Aug 2023 | zł2.8b | zł512.4m | -zł61,559,268.00 | 46.9x | -46x | 5.5x |
| Sat, 15 Jul 2023 | zł2.9b | zł512.4m | -zł61,559,268.00 | 46.5x | -46.6x | 5.6x |
| Mon, 12 Jun 2023 | zł2.9b | zł512.4m | -zł61,599,797.00 | 46.4x | -46.5x | 5.6x |
| Wed, 10 May 2023 | zł2.8b | zł505.4m | -zł64,921,034.00 | 68.6x | -43.2x | 5.5x |
| Fri, 07 Apr 2023 | zł2.8b | zł473.8m | -zł77,860,781.00 | 72.3x | -36x | 5.9x |
| Sun, 05 Mar 2023 | zł3.2b | zł473.8m | -zł77,860,781.00 | 81.9x | -41.3x | 6.8x |
| Tue, 31 Jan 2023 | zł3.0b | zł483.0m | -zł79,277,613.00 | 61.8x | -37.8x | 6.2x |
| Thu, 29 Dec 2022 | zł2.8b | zł470.4m | -zł90,293,852.00 | 57.7x | -30.8x | 5.9x |
| Sat, 26 Nov 2022 | zł2.3b | zł473.2m | -zł84,720,511.00 | 34.9x | -27.3x | 4.9x |
| Mon, 24 Oct 2022 | zł2.3b | zł445.7m | -zł96,033,392.00 | 60.6x | -24x | 5.2x |
| Wed, 21 Sep 2022 | zł2.2b | zł443.8m | -zł81,492,827.00 | 53.6x | -27.3x | 5x |
| Fri, 19 Aug 2022 | zł2.3b | zł417.3m | -zł76,832,012.00 | 59.6x | -29.6x | 5.4x |
| Sun, 17 Jul 2022 | zł2.0b | zł417.3m | -zł76,832,012.00 | 51.4x | -25.9x | 4.8x |
| Tue, 14 Jun 2022 | zł1.9b | zł417.3m | -zł76,832,012.00 | 52.4x | -24.1x | 4.4x |
| Thu, 12 May 2022 | zł2.1b | zł383.3m | -zł65,630,938.00 | 49.8x | -32.2x | 5.5x |
| Sat, 09 Apr 2022 | zł2.4b | zł383.1m | -zł63,046,404.00 | 51.2x | -37.6x | 6.2x |
| Mon, 07 Mar 2022 | zł2.1b | zł316.7m | -zł60,433,049.00 | 53.1x | -34.5x | 6.6x |
| Wed, 02 Feb 2022 | zł2.4b | zł310.5m | -zł60,441,559.00 | 60.9x | -40.2x | 7.8x |
| Fri, 31 Dec 2021 | zł2.7b | zł310.5m | -zł60,562,303.00 | 68.7x | -45.2x | 8.8x |
| Sun, 28 Nov 2021 | zł2.6b | zł310.7m | -zł59,400,949.00 | 63.8x | -44.1x | 8.4x |
Price to Earnings Ratio
-44.1x
Current Industry PE
- Investors are relatively neutral on the Polish Life Sciences industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 5.8x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 11% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | -3.15% | |
| Healthcare | -3.64% | |
| Life Sciences | -7.36% | |
| Clinical Research and Equipment | -7.36% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MDB Medicofarma Biotech | zł0.41 | 5.7% +zł1.5m | -63.1% | PS20.4x |